Nrf2 activators as potential modulators of injury in human kidney cells

Cisplatin is a chemotherapeutic agent used in the treatment of solid tumors, with clinical use often complicated by kidney toxicity. Nuclear factor (erythroid-derived-2)-like 2 (Nrf2) is a transcription factor involved in kidney protectant effects. The purpose of this study was to determine whether...

Descripción completa

Detalles Bibliográficos
Autores principales: Atilano-Roque, Amandla, Wen, Xia, Aleksunes, Lauren M., Joy, Melanie S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5615789/
https://www.ncbi.nlm.nih.gov/pubmed/28959534
http://dx.doi.org/10.1016/j.toxrep.2016.01.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5615789/
https://www.ncbi.nlm.nih.gov/pubmed/28959534
http://dx.doi.org/10.1016/j.toxrep.2016.01.006

Ejemplares similares